Cogent Biosciences (COGT) Cash & Current Investments (2017 - 2021)
Historic Cash & Current Investments for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $202.9 million.
- Cogent Biosciences' Cash & Current Investments rose 5676.71% to $202.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $202.9 million, marking a year-over-year increase of 5676.71%. This contributed to the annual value of $242.2 million for FY2020, which is 54715.16% up from last year.
- According to the latest figures from Q3 2021, Cogent Biosciences' Cash & Current Investments is $202.9 million, which was up 5676.71% from $218.1 million recorded in Q2 2021.
- Cogent Biosciences' 5-year Cash & Current Investments high stood at $242.2 million for Q4 2020, and its period low was $21.3 million during Q2 2020.
- Moreover, its 5-year median value for Cash & Current Investments was $82.5 million (2018), whereas its average is $107.1 million.
- Per our database at Business Quant, Cogent Biosciences' Cash & Current Investments plummeted by 6187.75% in 2019 and then skyrocketed by 92195.2% in 2021.
- Cogent Biosciences' Cash & Current Investments (Quarter) stood at $49.6 million in 2017, then soared by 97.56% to $97.9 million in 2018, then crashed by 61.79% to $37.4 million in 2019, then skyrocketed by 547.15% to $242.2 million in 2020, then decreased by 16.23% to $202.9 million in 2021.
- Its last three reported values are $202.9 million in Q3 2021, $218.1 million for Q2 2021, and $230.7 million during Q1 2021.